Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

OncoGenex Pharmaceuticals' OGX-011 granted FDA fast track status

OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.

24 Aug 2008

Eli Lilly acquires SGX Pharmaceuticals

Eli Lilly and Company has announced that it has completed the acquisition of SGX Pharmaceuticals, Inc. (Public, NASDAQ:SGXP), a San Diego-based biotechnology company focused on drug discovery and development in the area of oncology.

20 Aug 2008

Brachytherapy may benefit obese prostate cancer patients

Brachytherapy, also called seed implants, may be a more beneficial treatment than surgery or external beam radiation therapy for overweight or obese prostate cancer patients, according to a study published in the August issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.

19 Aug 2008

Experimental chemo shows promise in treating advanced non-small cell lung cancer

A combination of chemotherapy agents that have been tested in other tumor types appears to be a promising alternative to standard treatment for advanced non-small cell lung cancer, according to a report in the August 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.

12 Aug 2008

Precisely targeted radiation therapy can control limited cancer spread

Precisely targeted radiation therapy can eradicate all evidence of disease in selected patients with cancer that has spread to only a few sites, suggests the first published report from an ongoing clinical trial.

12 Aug 2008

MicroRNAs help control blood-vessel development

The development and repair of heart tissue and blood vessels is intimately tied to a tiny piece of ribonucleic acid (RNA) that is found nowhere else in the body, researchers at UT Southwestern Medical Center have found.

12 Aug 2008

Scientists discover link between DNA copy number changes and cancer risk

Scientists at The Hospital for Sick Children (SickKids) have discovered a link between a newly discovered form of inherited genetic alteration, termed DNA copy number variation (CNV), and cancer susceptibility.

4 Aug 2008

Disparities in prostate cancer treatment suggest ways to improve care

Quality of care varies greatly for the treatment of men with early-stage prostate cancer by region of the country and category of health care facility, suggesting the potential for improved patient outcomes with more standard treatment protocols, according to a new study that was published in the Aug. 1 issue of the Journal of Clinical Oncology (2008: Vol. 26, Issue 22).

3 Aug 2008

Immunotherapy shows promise in high-risk pediatric sarcomas

Based on a pilot study in children with sarcoma, researchers at the National Institutes of Health (NIH) believe that immunotherapy could prove beneficial in treating high-risk forms of this cancer.

3 Aug 2008

The Kenneth B. Schwartz Center, ASTRO partner to raise awareness of cancer survivorship

As part of its continued effort to give back to the cancer communities in the cities visited during its annual scientific meeting, the Fairfax, Va.-based American Society for Therapeutic Radiology and Oncology (ASTRO) is partnering with the Kenneth B. Schwartz Center to raise awareness of cancer survivorship. The Kenneth B. Schwartz Center conducts pioneering programs to educate, train and support caregivers in the art of compassionate healthcare.

31 Jul 2008

Robotic surgery now benefits bladder cancer patients

Robotic surgery, largely pioneered for prostate cancer surgery, is rapidly being adapted for use in other areas, including for bladder cancer patients. Urologic surgeons at NewYork-Presbyterian Hospital/Weill Cornell Medical Center now have significant experience -- and have demonstrated considerable success -- with robotics for removal of the bladder, also known as cystectomy.

30 Jul 2008

New understanding of exaggerated mucous production and secretion in cystic fibrosis

A London, Canada scientist studying cystic fibrosis (CF) has successfully corrected the defect which causes the overproduction of intestinal mucous in mice.

29 Jul 2008

Chemo and radiation after surgery prolongs life for pancreatic cancer patients

Pancreatic cancer patients treated with a combination of chemotherapy and radiation after surgery survive approximately six months longer than those receiving surgery alone, Johns Hopkins Kimmel Cancer Center scientists report.

24 Jul 2008

Roche starts acquisition process of ARIUS - fast tracks access to screening platform for antibody therapeutics

Roche and ARIUS Research Inc. have announced that the two companies have signed a definitive agreement for Roche to acquire ARIUS in an all-cash transaction at a price of approximately C$191 million.

23 Jul 2008

Notch protein helps human embryonic stem cells 'decide' their own fate

Researchers at Johns Hopkins have discovered that the Notch protein helps human embryonic stem cells 'decide' their own fate, a finding which may eventually be useful in programming cells for the development of stem cell therapies. Their results are reported in the May 2008 issue of Cell Stem Cell.

22 Jul 2008

End of life physician-patient communication

Although a growing body of research supports a link between effective communication and patient, family and physician satisfaction, doctors, including oncologists and other specialists who frequently care for terminal patients, do not routinely receive training in end-of-life conversations during medical school, residency training, or after they start to practice medicine.

22 Jul 2008

Abiraterone new drug for aggressive prostate cancer the best thing in 70 years

Scientists say a new drug which treats aggressive prostate cancer is possibly the most significant development in the field for 70 years.

22 Jul 2008

First human tests of an injectable vaccine grown in genetically engineered plants

Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants.

21 Jul 2008

Gene expression test could help determine who needs more aggressive treatment

Researchers from four leading cancer centers have confirmed that an analysis involving a panel of genes can be used to predict which lung cancer patients will have the worst survival. The finding could one day lead to a test that would help determine who needs more aggressive treatment.

21 Jul 2008

Penn partnership designed to eliminate childhood obesity wins prize

Students from the University of Pennsylvania School of Nursing Pediatric Acute/Chronic and Oncology Nurse Practitioner program earned first place for their research poster at the 24th Annual Pediatric Nursing National Conference in Las Vegas.

21 Jul 2008